Literature DB >> 10541088

Percutaneous liver biopsy: a cost-benefit analysis comparing sonographic and CT guidance.

M A Kliewer1, D H Sheafor, E K Paulson, R S Helsper, B S Hertzberg, R C Nelson.   

Abstract

OBJECTIVE: We compared the relative cost of a liver biopsy performed with sonographic guidance with that of one performed with CT guidance in a cost-benefit analysis model.
MATERIALS AND METHODS: Variables were estimated from a search of the literature and from clinical experience with 437 hepatic biopsies at our institution. Probability variables included the probability of obtaining an adequate sample and the probability of a major complication. Cost variables included the direct and indirect costs, the cost of a major complication, and the opportunity costs of foregone revenue from preempted diagnostic studies. One-way and two-way sensitivity analyses were performed.
RESULTS: Using baseline values, CT guidance was 1.89 times more expensive than sonographic guidance. Sensitivity analyses indicate that CT and sonographic guidance costs would be equivalent if the success rate with sonographic guidance was 39.8%, the opportunity costs of CT guidance were 3.13 times less than best estimates, and the opportunity costs of sonography were 3.15 times greater than best estimates.
CONCLUSION: Sonographic guidance for hepatic biopsies is substantially more economical than CT guidance across a wide range of estimated costs.

Mesh:

Year:  1999        PMID: 10541088     DOI: 10.2214/ajr.173.5.10541088

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Liver biopsy: when, how, by whom, and where?

Authors:  D B McGill
Journal:  Curr Gastroenterol Rep       Date:  2001-02

2.  Cost comparison analysis of low-field (0.23 T) MRI- and CT-guided bone biopsies.

Authors:  J Alanen; L Keski-Nisula; R Blanco-Sequeiros; O Tervonen
Journal:  Eur Radiol       Date:  2003-06-25       Impact factor: 5.315

3.  MR-guided biopsies with a newly designed cordless coil in an open low-field system: initial findings.

Authors:  Stephan Zangos; Theodor Vetter; Frank Huebner; Montu Tuwari; Florian Mayer; Katrin Eichler; M-L Hansmann; A Wetter; C Herzog; Thomas J Vogl
Journal:  Eur Radiol       Date:  2005-12-13       Impact factor: 5.315

Review 4.  Interventional real-time ultrasound imaging with an integrated electromagnetic field generator.

Authors:  K März; A M Franz; A Seitel; A Winterstein; M Hafezi; A Saffari; R Bendl; B Stieltjes; H-P Meinzer; A Mehrabi; L Maier-Hein
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-03-25       Impact factor: 2.924

5.  [Ultrasound-guided image fusion with computed tomography and magnetic resonance imaging. Clinical utility for imaging and interventional diagnostics of hepatic lesions].

Authors:  D-A Clevert; A Helck; P M Paprottka; P Zengel; C Trumm; M F Reiser
Journal:  Radiologe       Date:  2012-01       Impact factor: 0.635

6.  A novel CT-guided transpsoas approach to diagnostic genitofemoral nerve block and ablation.

Authors:  David Parris; Nancy Fischbein; Sean Mackey; Ian Carroll
Journal:  Pain Med       Date:  2010-05       Impact factor: 3.750

7.  Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients.

Authors:  Zhu Cui; Jason D Wright; Melissa K Accordino; Donna Buono; Alfred I Neugut; Jim C Hu; Dawn L Hershman
Journal:  Cancer Invest       Date:  2016-04-11       Impact factor: 2.176

Review 8.  Ultrasound-guided biopsy of challenging abdominopelvic targets.

Authors:  Edward M Lawrence; Meghan G Lubner; Perry J Pickhardt; Michael P Hartung
Journal:  Abdom Radiol (NY)       Date:  2021-07-28

9.  Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Lu-Hung Lee; Jen-I Hwang; Yu-Chi Cheng; Chun-Ying Wu; Shou-Wu Lee; Sheng-Shun Yang; Hong-Zen Yeh; Chi-Sen Chang; Teng-Yu Lee
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.